Ensol Biosciences Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2017	FY 2016	FY 2015
Period Ending	Feb '26 Feb 18, 2026	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Debt / Equity Ratio	0.01	0.01	-	0.18
Net Debt / Equity Ratio	-0.39	-0.39	-0.60	-0.55
Net Debt / EBITDA Ratio	0.54	0.54	1.66	2.99
Net Debt / FCF Ratio	0.54	0.54	1.97	2.23
Asset Turnover	0.05	0.05	0.01	-
Quick Ratio	8.46	8.46	12.53	3.74
Current Ratio	9.01	9.01	12.84	3.79
Return on Equity (ROE)	-59.14%	-59.14%	-54.70%	-
Return on Assets (ROA)	-31.45%	-31.45%	-22.54%	-
Return on Capital Employed (ROCE)	-70.70%	-70.70%	-37.90%	-20.50%
Buyback Yield / Dilution	-	-1.79%	-22.68%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.